A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of single ascending dose study is to evaluate the safety and
tolerability of CY150112 after single oral administration of different doses in healthy
Chinese subjects.